Section 8000: General Information
8001: Review
SOPP 8001.2: Accessing the FDA Lists of Disqualified and Restricted Clinical Investigators, Debarred Individuals, and Firms Under the FDA Application Integrity Policy
Effective Date: February 25, 2020
SOPP 8001.4: Review of Proprietary Names for CBER Regulated Products
Effective Date: December 13, 2023
SOPP 8001.6: Procedures for Parallel Scientific Advice with European Medicines Agency (EMA)
Effective Date: January 12, 2023
SOPP 8004: Tissue Reference Group
Effective Date: February 27, 2023
SOPP 8005: Formal Dispute Resolution Process
Effective Date: February 27, 2023
SOPP 8006: Resolution of Differences in Scientific Judgement in the Review Process
Effective Date: January 15, 2009